{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:13:46Z","timestamp":1791994426621,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jtho.2017.11.131","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:40:07Z","timestamp":1513172407000},"page":"576-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non\u2013Small Cell Lung Cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"Enriqueta","family":"Felip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Barlesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quincy","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-We","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Carcereny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lecia V.","family":"Sequist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paal","family":"Brunsvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Chouaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert F.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.M.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunchil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin","family":"Avsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Szpakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Akimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Garon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2017.11.131_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1078-0432.CCR-08-0132","article-title":"Heat shock protein 90 as a drug target: some like it hot","volume":"15","author":"Banerji","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.11.131_bib2","doi-asserted-by":"crossref","first-page":"e0001722","DOI":"10.1371\/journal.pone.0001722","article-title":"Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target","volume":"3","author":"Gallegos Ruiz","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.jtho.2017.11.131_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/jm701018h","article-title":"4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer","volume":"51","author":"Brough","year":"2008","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jtho.2017.11.131_bib4","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-07-5256","article-title":"NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis","volume":"68","author":"Eccles","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.11.131_bib5","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/bcr1996","article-title":"NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models","volume":"10","author":"Jensen","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jtho.2017.11.131_bib6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/1535-7163.MCT-09-0683","article-title":"Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma","volume":"9","author":"Gaspar","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtho.2017.11.131_bib7","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1158\/1078-0432.CCR-12-3404","article-title":"First-in-human phase I dose-escalation study of the HSP90 inhibitor AUY922 in patients with advanced solid tumors","volume":"19","author":"Sessa","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.11.131_bib8","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1158\/1535-7163.MCT-12-0615","article-title":"Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespib","volume":"11","author":"Acquaviva","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtho.2017.11.131_bib9","doi-asserted-by":"crossref","first-page":"120ra117","DOI":"10.1126\/scitranslmed.3003316","article-title":"Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers","volume":"4","author":"Katayama","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtho.2017.11.131_bib10","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1311107","article-title":"Ceritinib in ALK-rearranged non\u2013small-cell lung cancer","volume":"370","author":"Shaw","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2017.11.131_bib11","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1158\/1078-0432.CCR-12-3381","article-title":"A\u00a0multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer","volume":"19","author":"Socinski","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.11.131_bib12","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1200\/JCO.2010.30.8338","article-title":"Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer","volume":"28","author":"Sequist","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.11.131_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.canlet.2008.02.064","article-title":"Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals","volume":"265","author":"Zhu","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtho.2017.11.131_bib14","doi-asserted-by":"crossref","unstructured":"Piotrowska Z, Smit E, Costa DB, et\u00a0al. Activity of AUY922 in NSCLC patinets with EGFR exon 20 insertions. Paper presented at: 16th World Conference on Lung Cancer. September 6\u20139, 2015; Denver, CO.","DOI":"10.1200\/jco.2015.33.15_suppl.8015"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417330836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417330836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T20:09:54Z","timestamp":1570478994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086417330836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1556086417330836"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2017.11.131","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non\u2013Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2017.11.131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}